The agenda for the 25th edition of LogiPharma is now live, highlighting an impressive list of speakers and seminars for this important event.
LogiPharma, which will be held in Lyon from April 8 to 10, is set to welcome 2,500 delegates from across the pharmaceutical and life sciences logistics sector. The event also includes LogiMed, the world’s leading medical device supply chain event.
As in previous years, LogiPharma provides delegates with multiple touchpoints to gain knowledge and network with industry peers – from discovering the latest innovations being brought to market by event sponsors in the exhibitor area, to creating a personalized experience with specific industry “tracks” related to With their products. Knowledge needs.
Tracks in LogiPharma 2025 include strategy development, planning and network design; Delivering next-generation digital supply chains; Mastery of temperature-controlled processes; improving interconnected logistics, distribution and warehousing services; Advances in purchasing and supplier management; Value Chain Transformation – Clinical Integration and Launch Management; manufacturing integration; And a conference dedicated to MedTech supply chains.
For delegates looking to keep up with the latest trends and topics, plenary sessions in the main hall offer a carefully curated program of talks and panels by industry leaders.
While participating in a keynote interview on integrated launch readiness during the first day of the event, Wayne Rothman, Vice President of Global Value Chain Management at Johnson & Johnson, said: “The scope and scale of discussions for LogiPharma’s 25th anniversary feel bigger and better than ever. “I’m looking forward to April.”
Highlights from the plenary session on day one include a key case study presented by Stephen Lang, COO and member of the Executive Committee at Novartis. Titled Delivering Technology-Driven Process Transformation: How to Deliver Increased Productivity and Connection with Patients, Stefan will explore how to create lasting change that accelerates growth, strengthens the pipeline and increases productivity.
This is followed by a keynote panel discussion on the Law of Operational Balance, asking how to achieve the goals of sustainability, flexibility and efficiency while ensuring better patient outcomes.
Later that day, an inspiring keynote speaker will be delivered – always a popular spot among delegates – by international mountaineer and 18-time summiteer of Everett, Kenton Cole.
Additional inspiration will follow from John Setilides, a senior fellow in the National Security Program at the Foreign Policy Research Institute who will provide insights into Trump, Putin, Xi Jinping, and the Global Life Sciences Supply Chain: The New Geopolitics of Trade, Energy, Diplomacy, and War.
The hot topic of AI permeates the agenda, including a dedicated AI Focus Day, centered around practically separating the hype from reality, a keynote presentation by Ruth Biddle, Sanofi’s Chief Supply Chain Officer. Ruth will share Sanofi’s “All In on AI” story: how to integrate E2E and deliver the “miracles of science” to your patients, and additional key perspectives from industry heavyweights such as Alessandro De Luca, Global CIO, Merck Group and Brian Thornley, Vice President. Global Supply Chain Excellence, Moderna on the subject.
The final day includes a packed agenda of conversations on topics ranging from improving healthcare and patient collaboration to achieving transformation across industries.
“LogiPharma brings together industry leaders to discuss how new trends in the life sciences and healthcare sectors are impacting our customers’ supply chains, making it an essential event to stimulate innovation in pharmaceutical logistics,” said Oscar de Bock, CEO of DHL Supply Chain.
“Every year, we listen to what past and potential delegates care about, and we’ve built a highly diverse schedule to ensure LogiPharma attendees get insights and connections they won’t get anywhere else,” said Will Robinson, LogiPharma Conference Director.
“From the impact and growth of artificial intelligence to the increasing demands of sustainability, the agenda reflects the vibrant and exciting state of the end-to-end pharmaceutical and medical device supply chain in 2025.”
